Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 13, Issue 6, Pages 919-949
Publisher
Mary Ann Liebert Inc
Online
2010-01-23
DOI
10.1089/ars.2009.2929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
- (2017) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
- (2017) Muralidhar L. Hegde et al. JOURNAL OF ALZHEIMERS DISEASE
- Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
- (2017) Sandro Altamura et al. JOURNAL OF ALZHEIMERS DISEASE
- Small Molecule Activation of Adaptive Gene Expression
- (2010) Rajiv R. Ratan et al. Annals of the New York Academy of Sciences
- Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection
- (2009) Sarah K. Harten et al. ANTIOXIDANTS & REDOX SIGNALING
- Tumor Vasculature Is Regulated by PHD2-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment
- (2009) Denise A. Chan et al. CANCER CELL
- A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding
- (2009) Nathan R. Perron et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration?
- (2009) O. O. Ogunshola et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Recent advances in the genetics of amyotrophic lateral sclerosis
- (2009) Paul N. Valdmanis et al. Current Neurology and Neuroscience Reports
- Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
- (2009) Lana Kupershmidt et al. FASEB JOURNAL
- Parkinson's disease: from monogenic forms to genetic susceptibility factors
- (2009) S. Lesage et al. HUMAN MOLECULAR GENETICS
- Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity
- (2009) Donna W. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIF-2α, but not HIF-1α, promotes iron absorption in mice
- (2009) Maria Mastrogiannaki et al. JOURNAL OF CLINICAL INVESTIGATION
- The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
- (2009) Orit Bar-Am et al. JOURNAL OF NEUROCHEMISTRY
- Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2009) S. Y. Jeong et al. JOURNAL OF NEUROSCIENCE
- Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
- (2009) A. Siddiq et al. JOURNAL OF NEUROSCIENCE
- HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo
- (2009) Louise Witten et al. JOURNAL OF NEUROSCIENCE RESEARCH
- VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
- (2009) Roberto Del Bo et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Chelation therapy for neurodegenerative diseases
- (2009) Silvia Bolognin et al. MEDICINAL RESEARCH REVIEWS
- The curious case of clioquinol
- (2009) Lauren Cahoon NATURE MEDICINE
- Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
- (2009) Peter Fraisl et al. NATURE REVIEWS DRUG DISCOVERY
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Brain iron homeostasis and neurodegenerative disease
- (2009) E. E. Benarroch NEUROLOGY
- Brain iron deficiency and excess; cognitive impairment and neurodegenration with involvement of striatum and hippocampus
- (2009) Moussa B. H. Youdim NEUROTOXICITY RESEARCH
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stringency of the 2-His–1-Asp Active-Site Motif in Prolyl 4-Hydroxylase
- (2009) Kelly L. Gorres et al. PLoS One
- Alzheimer's disease, metal ions and metal homeostatic therapy
- (2009) Paolo Zatta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antioxidants, HIF Prolyl Hydroxylase Inhibitors or Short Interfering RNAs to BNIP3 or PUMA, Can Prevent Prodeath Effects of the Transcriptional Activator, HIF-1α, in a Mouse Hippocampal Neuronal Line
- (2008) Leila R. Aminova et al. ANTIOXIDANTS & REDOX SIGNALING
- The application of proteomics for studying the neurorescue activity of the polyphenol (−)-epigallocatechin-3-gallate
- (2008) Orly Weinreb et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?
- (2008) Barry Halliwell ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease
- (2008) Jack T. Rogers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Iron chelation as a potential therapy for neurodegenerative disease
- (2008) Robert C. Hider et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1α stabilization in the host brain
- (2008) Kon Chu et al. BRAIN RESEARCH
- Up-regulated HIF-1α is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioning
- (2008) Zhaoyun Peng et al. BRAIN RESEARCH
- Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
- (2008) Kavon Rezai-Zadeh et al. BRAIN RESEARCH
- The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
- (2008) Orly Weinreb et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Concentration dependent antioxidant/pro-oxidant activity of curcumin
- (2008) Arnab Banerjee et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
- (2008) Ying Liu et al. FEBS LETTERS
- Predicting How Polyphenol Antioxidants Prevent DNA Damage by Binding to Iron
- (2008) Nathan R. Perron et al. INORGANIC CHEMISTRY
- Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration
- (2008) Wen Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Glucose up-regulates HIF-1α expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status
- (2008) Shuhong Guo et al. JOURNAL OF NEUROCHEMISTRY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- The von Hippel-Lindau Tumor Suppressor Protein and Egl-9-Type Proline Hydroxylases Regulate the Large Subunit of RNA Polymerase II in Response to Oxidative Stress
- (2008) O. Mikhaylova et al. MOLECULAR AND CELLULAR BIOLOGY
- A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
- Long-Term Functional and Protective Actions of Preconditioning With Hypoxia, Cobalt Chloride, and Desferrioxamine Against Hypoxic-Ischemic Injury in Neonatal Rats
- (2008) Nicole M Jones et al. PEDIATRIC RESEARCH
- Brain Protection by Erythropoietin: A Manifold Task
- (2008) Tamer Rabie et al. PHYSIOLOGY
- Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
- (2008) B TURNER et al. PROGRESS IN NEUROBIOLOGY
- The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?
- (2008) Hirokazu Fukui et al. TRENDS IN NEUROSCIENCES
- Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin
- (2008) Yun-Xia Li et al. Neuroscience Bulletin
- Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
- (2007) Mauro Cozzolino et al. ANTIOXIDANTS & REDOX SIGNALING
- Vascular Endothelial Growth Factor and Nitric Oxide Production in Response to Hypoxia in the Choroid Plexus in Neonatal Brain
- (2007) Viswanathan Sivakumar et al. BRAIN PATHOLOGY
- Flavonoids induce HIF-1α but impair its nuclear accumulation and activity
- (2007) Anastasia Triantafyllou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Prolyl 4-hydroxylase activity-responsive transcription factors: From hydroxylation to gene expression and neuroprotection
- (2007) Ambreena Siddiq Frontiers in Bioscience-Landmark
- Ginkgolides protect PC12 cells against hypoxia-induced injury by p42/p44 MAPK pathway-dependent upregulation of HIF-1α expression and HIF-1DNA-binding activity
- (2007) Zhu Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1α/2α is mediated through chelation of iron
- (2007) Sung-Soo Park et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Brain iron pathways and their relevance to Parkinson's disease
- (2003) D Berg et al. JOURNAL OF NEUROCHEMISTRY
- Characterization of Copper Interactions with Alzheimer Amyloid β Peptides
- (2003) Craig S. Atwood et al. JOURNAL OF NEUROCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started